Eplerenone Tablet, Film Coated
Product Images NDC 16729-293

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Eplerenone (NDC 16729-293). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Accord Healthcare, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Eplerenone Fig 3)

Figure (Eplerenone Fig 3)
This is a data figure showing the Eplerenone dose response in hypertension studies. The y-axis displays the placebo-subtracted adjusted mean change from baseline in trough cuff systolic blood pressure (SBP). The x-axis shows the Eplerenone dose in milligrams per day. There are three studies represented; Study 1 had a once-daily dose of 50mg, Study 2 had a once-daily dose of 100mg or twice-daily dose of 50mg, and Study 3 had a once-daily dose of 200mg.*
FDA Label Image

Figure (Eplerenone Fig 4)

Figure (Eplerenone Fig 4)
The text describes a figure (Figure 4) depicting the dose-response relationship of eplerenone on trough cuff DBP (diastolic blood pressure) in hypertension studies. The figure shows placebo-subtracted adjusted mean change from baseline in DBP for eplerenone doses ranging from 0 mg/day to 200 mg/day. The figure includes three studies, identified as Study 1 QD, Study 2 QD, and Study 2 BID. The y-axis units are not mentioned. There are some unusual characters in the text that may be the result of errors.*
FDA Label Image

Principal Display Panel (25 mg Tablet)

Principal Display Panel (25 mg Tablet)
This is a medication called Eplerenone, which is delivered in film-coated tablets of 25mg each. The recommended dosage should be followed as indicated. The tablets should be stored at a temperature between 15°C to 30°C, and no other data is available. The manufacturer is Accord Healthcare, based in Durham, NC but the tablets are manufactured by Intas Pharmaceuticals Limited in Ahmedabad, India. The tablets come in a package of 30 and the lot information is expected to be printed on the blank space provided next to its data matrix. This medication requires a prescription.*
FDA Label Image

Principal Display Panel (50 mg Tablet)

Principal Display Panel (50 mg Tablet)
This is a description for Eplerenone tablets, each containing 50mg of the medication. The recommended dosage is not available and users are advised to refer to accompanying prescribing information. The tablets should be stored at a temperature between 16°C to 30°C. Manufacturing of the medication was done by Intas Pharmaceuticals Limited in India and is distributed by Accord Healthcare in Durham, NC. The tablets come in a container of 30 and can only be acquired through a prescription. There is a manufacturing license number at the bottom of the document.*
FDA Label Image

Chemical Structure (Eplerenone Struc)

Chemical Structure (Eplerenone Struc)
The description of the text is "eplerenone".*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.